DRUG NEWS
![whadocdontelyouaunz1908_article_014_01_01](https://article-imgs.scribdassets.com/9dwmi0sl347ocjsk/images/file2WWL0KPO.jpg)
Vaccine revenues set to soar after anti-vax clampdown
The clampdown on ‘anti-vax’ stories on social media is producing one big winner: Big Pharma. Revenues from vaccines will enjoy “an overwhelming hike” in the next few years, say industry watchers.
Market research group HTF Market Intelligence said revenues from the MMR vaccine will see the hike by 2025, and other research firms have also been forecasting big revenue increases for the global market for all vaccines.
Market research group Research & Markets estimates revenues for all vaccines will increase to $57.5 billion by 2025, compared to just $33.7 billion last year. Another market research group, Transparency, is forecasting vaccine sales revenues will reach $48 billion by 2025.
Government initiatives that
You’re reading a preview, subscribe to read more.
Start your free 30 days